Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-04-10 11:26 am Purchase |
2025-03-31 | 13G | INmune Bio, Inc. INMB |
Praetorian PR LLC | 1,657,200 7.200% |
418,237![]() (+33.76%) |
Filing History |
2025-01-15 3:41 pm Purchase |
2025-01-15 | 13G | INmune Bio, Inc. INMB |
Praetorian PR LLC | 1,238,963 5.500% |
1,238,963![]() (New Position) |
Filing History |
2024-10-25 10:15 am Purchase |
2024-09-30 | 13G | INmune Bio, Inc. INMB |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,454,400 6.600% |
1,454,400![]() (New Position) |
Filing History |
2024-10-02 4:50 pm Unchanged |
2023-12-31 | 13G | INmune Bio, Inc. INMB |
Xencor Inc XNCR |
1,885,533 9.600% |
0 (Unchanged) |
Filing History |
2023-02-15 5:06 pm Unchanged |
2022-12-31 | 13G | INmune Bio, Inc. INMB |
Xencor Inc XNCR |
1,885,533 10.500% |
0 (Unchanged) |
Filing History |
2022-04-21 4:30 pm Purchase |
2021-01-19 | 13D | INmune Bio, Inc. INMB |
Moss David J | 1,882,956 10.100% |
226,206![]() (+13.65%) |
Filing History |
2022-04-21 4:30 pm Purchase |
2021-07-07 | 13D | INmune Bio, Inc. INMB |
Lowdell Mark William | 2,046,383 11.100% |
120,132![]() (+6.24%) |
Filing History |
2022-04-21 4:30 pm Purchase |
2021-01-19 | 13D | INmune Bio, Inc. INMB |
Tesi Raymond Joseph | 2,155,403 11.600% |
181,137![]() (+9.17%) |
Filing History |
2022-02-14 06:09 am Sale |
2021-12-31 | 13G | INmune Bio, Inc. INMB |
Altium Capital Management LLC | 0 0.000% |
-909,091![]() (Position Closed) |
Filing History |
2022-02-10 12:40 pm Purchase |
2021-12-31 | 13G | INmune Bio, Inc. INMB |
Xencor Inc XNCR |
1,885,533 10.600% |
194,533![]() (+11.50%) |
Filing History |
2021-07-19 09:25 am Purchase |
2021-07-14 | 13G | INmune Bio, Inc. INMB |
Altium Capital Management LLC | 909,091 5.100% |
909,091![]() (New Position) |
Filing History |
2021-01-22 5:01 pm Purchase |
2020-12-31 | 13G | INmune Bio, Inc. INMB |
Xencor Inc XNCR |
1,691,000 12.500% |
36,000![]() (+2.18%) |
Filing History |